These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8037266)

  • 1. Desipramine in the treatment of depressed alcoholics.
    Mason BJ; Kocsis JH
    Am J Psychiatry; 1994 Aug; 151(8):1248. PubMed ID: 8037266
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating depression in alcoholics.
    Douglas MB; Fleming MF
    J Fam Pract; 1996 Jun; 42(6):565-6. PubMed ID: 8656162
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of desipramine in mildly depressed patients: a double-blind, placebo-controlled trial [proceedings].
    Stewart JW; Quitkin F; Liebowitz MR; McGrath PJ; Klein DF
    Psychopharmacol Bull; 1981 Jan; 17(1):136-8. PubMed ID: 7015394
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.
    Mason BJ; Kocsis JH; Ritvo EC; Cutler RB
    JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine treatment of alcoholism with comorbid depression.
    Nunes EV; McGrath PJ; Quitkin FM; Stewart JP; Harrison W; Tricamo E; Ocepek-Welikson K
    Am J Psychiatry; 1993 Jun; 150(6):963-5. PubMed ID: 8494079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desipramine treatment of alcoholism.
    Mason BJ; Kocsis JH
    Psychopharmacol Bull; 1991; 27(2):155-61. PubMed ID: 1924663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Perel JM; Thase ME; Black A
    Arch Gen Psychiatry; 1997 Aug; 54(8):700-5. PubMed ID: 9283504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mianserin in the treatment of depressive symptoms in alcoholics. A double-blind placebo controlled study using a computer delivered self-rating scale.
    McLean PC; Ancill RJ; Szulecka TK
    Psychiatr Pol; 1986; 20(6):417-27. PubMed ID: 3299432
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 12. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desipramine for the treatment of "pure" dysthymia versus "double" depression.
    Marin DB; Kocsis JH; Frances AJ; Parides M
    Am J Psychiatry; 1994 Jul; 151(7):1079-80. PubMed ID: 8010368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lithium treatment in alcoholism.
    Lejoyeux M; Adès J
    Alcohol Alcohol; 1993 May; 28(3):273-9. PubMed ID: 8352838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of doxepin and desipramine in patients with primary affective disorder.
    Amsterdam JD; Caroff S; Potter L; Brunswick D; Conn JW; Rickels K
    Acta Psychiatr Scand; 1982 Apr; 65(4):292-300. PubMed ID: 7044045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
    Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
    Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
    Bystritsky A; Waikar SV
    J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retreatment for relapse following desipramine discontinuation in dysthymia.
    Friedman RA; Mitchell J; Kocsis JH
    Am J Psychiatry; 1995 Jun; 152(6):926-8. PubMed ID: 7755126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant pharmacotherapy of depression associated with multiple sclerosis.
    Schiffer RB; Wineman NM
    Am J Psychiatry; 1990 Nov; 147(11):1493-7. PubMed ID: 2221162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of desipramine in depressed inpatients.
    Nelson JC
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):10-6. PubMed ID: 6384205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.